These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?]. de los Santos-Sastre S An Med Interna; 1993 Sep; 10(9):465-6. PubMed ID: 8218806 [No Abstract] [Full Text] [Related]
7. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Hirsh J Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406 [No Abstract] [Full Text] [Related]
8. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin. Bergqvist D Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463 [No Abstract] [Full Text] [Related]
9. Review of clinical trials of low molecular weight heparins. Bergqvist D Eur J Surg; 1992 Feb; 158(2):67-78. PubMed ID: 1350218 [No Abstract] [Full Text] [Related]
10. Management of venous thromboembolism: optimization by clinical trials. Turpie AG Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of low molecular weight heparins (LMWH) in the prevention of venous thromboembolism (VTE). Kakkar VV Thromb Haemost; 1995 Jul; 74(1):364-8. PubMed ID: 8578486 [TBL] [Abstract][Full Text] [Related]
12. [Low molecular weight heparins. Implications in anesthesia and resuscitation]. Llau JV; Hoyas L; Ezpeleta J; García-Polit J; Barberá M; Santes MJ Rev Esp Anestesiol Reanim; 1997 Feb; 44(2):70-8. PubMed ID: 9148359 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement. Eriksson BI; Kälebo P; Risberg B Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714 [No Abstract] [Full Text] [Related]
14. An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism. Haas S; Blümel G Semin Thromb Hemost; 1989 Oct; 15(4):424-34. PubMed ID: 2554503 [No Abstract] [Full Text] [Related]
17. Letters on management of ischemic stroke. Porat G Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038 [No Abstract] [Full Text] [Related]
18. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?]. Roĭtman EV; Dement'eva II; Meshcheriakov AV Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253 [No Abstract] [Full Text] [Related]
19. Prevention of thrombosis during pregnancy. Vilela VS; de Jesús NR; Levy RA Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343 [No Abstract] [Full Text] [Related]
20. Exploring the role of low-molecular-weight heparins in pregnancy. Greer IA Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]